Claire Zangerle, Chief Nurse Executive, Allegheny Health Network (AHN)

“We recognize giving up time on the weekends after a busy week at a nurse’s regular job is difficult, so we are recognizing that sacrifice and commitment with this new program.” Claire Zangerle, Chief Nurse Executive, AHN

PITTSBURGH (PRWEB)
November 07, 2022

Allegheny Health Network(AHN) has launched a unique Weekend Nurse Program as part of its continuing efforts to address the labor shortages impacting the health care industry nationwide. Open to nurses across the region, regardless of where they work, the new AHN program is designed to provide flexible work-life solutions.

Unlike the traditional weekend programs nurses are accustomed to, the new AHN Weekend Nurse Program provides nurses the opportunity to make extra money on their terms and schedules. Without disrupting their current work schedule during the week, they can pick up shifts on the weekend at any AHN hospital. The commitment can be as little as one eight-hour shift a month, or as many as six 12-hour shifts a month on the weekends of their choosing. The program is open to nurses who currently work at hospitals outside of AHN, with rates of $85 per hour, as well as AHN exempt non-bedside nurses, who will earn time and a half plus $48 per hour. The program will be in place through the first quarter of 2023.

“The nursing shortage continues to impact hospitals and healthcare systems across the country,” said AHN Chief Nurse Executive Claire Zangerle, DNP, RN, FAAN. “We must continually develop creative solutions to ease the burden on our current staff while providing others with the opportunity to join our community of AHN nurses in unique ways. We are building the workforce of the future while supporting the workforce of the present.”

Continuing, Zangerle said nurses in the new program can pick up a shift or two on any given weekend and essentially be compensated about as much as they would make in a week of wages.

“We recognize giving up time on the weekends after a busy week at a nurse’s regular job is difficult, so we are recognizing that sacrifice and commitment with this new program,” Zangerle said. “We urge anyone interested to visit ahn.org/weekend-nurse for more information and to learn more about the various nursing opportunities available at AHN. Our “Work Your Way” nurse lifestyle program provides nurses with the freedom and flexibility to work in a way that suits their individual needs.”

Qualified nurse applicants are needed at the following AHN hospitals: Allegheny General, West Penn, Forbes, Jefferson, Wexford, Canonsburg, Allegheny Valley, and Saint Vincent. Nurses will be quickly on-boarded to units where the need is greatest, including medical-surgical and telemetry.

Other innovative offerings in the AHN “Work Your Way” program include a mobile internal staffing team model in which nurses are deployed to different AHN hospitals based on the needs of patients; and the traditional “weekend warrior” and “night owl” programs for AHN nurses who prefer to make those their primary jobs.

Zangerle said nurses at AHN are empowered to practice at their highest level in all settings, putting the patient at the center of their work by embracing evidence-based practices and collaborating across clinical disciplines.

About the Allegheny Health Network:

Allegheny Health Network (AHN.org) is an integrated healthcare delivery system serving the greater Western Pennsylvania region. The Network is composed of 14 hospitals, ambulatory surgery centers, Health + Wellness Pavilions, an employed physician organization, home and community-based health services, a research institute, and a group purchasing organization. The Network provides patients with access to a complete spectrum of advanced medical services, including nationally recognized programs for primary and emergency care, trauma care, cardiovascular disease, organ transplantation, cancer care, orthopedic surgery, neurology and neurosurgery, women’s health, diabetes, autoimmune disease and more. AHN employs approximately 21,000 people, has more than 2,600 physicians on its medical staff and serves as a clinical campus for Drexel University College of Medicine and the Lake Erie College of Osteopathic Medicine.

Share article on social media or email:

“Beacon’s advanced search capability will help increase productivity, streamline workflows, and improve scientific information exchanges for our user community”, said Eric Chen, VP of Engineering.

SAN FRANCISCO (PRWEB)
November 07, 2022

Alucio™, a fast-growing provider of cloud-based software for the life sciences industry, today announced the integration of artificial intelligence (AI) and machine learning (ML) capabilities into Beacon to enhance the platform’s search functionality. Beacon is a modern content activation and HCP engagement platform built specifically for Medical Science Liaisons (MSLs), Medical Affairs professionals and Market Access teams.

This new update will provide users with a powerful and intelligent full-text search feature to find and locate various documents quickly on the platform. Beacon’s search engine is consistently available throughout the application and is one of the most popular and frequently used features. It helps users discover, customize, share, and present content with ease.

By supercharging Beacon’s search capabilities with intelligent full-text search, powered by machine learning and natural language processing (NLP), users’ search results will now be even more targeted and relevant.

In essence, Beacon’s enhanced search feature acts as a smart assistant, helping users more quickly sort through all varieties of content, including rich media, and ensuring users are directed to the most relevant documents for their search. This is especially important in life science companies that are managing a significant amount of complex medical and scientific content.

“Beacon’s advanced search capability will help increase productivity, streamline workflows, and improve scientific information exchanges for our user community”, said Eric Chen, VP of Engineering. “Intelligent full-text search allows us to improve upon keyword-based search by leveraging machine learning and NLP to better match content stored in Beacon with user searches.

To learn more about Beacon and to schedule a product demonstration, please contact the company at sales@alucio.io.

About Alucio:

Alucio is dedicated to the development of innovative software applications specifically for the life sciences industry. Alucio’s flagship product, Beacon, is a modern, cloud-based scientific exchange platform that enhances scientific dialogue and engagement between life science companies and healthcare professionals. For more information, please visit the company’s website at http://www.alucio.io or contact Lisa Amin at lamin@alucio.io (925) 788-3533.

Share article on social media or email:

“Physicians and patients have long sought a modern alternative to acne pills, peels and topicals, we are excited to be one of the few clinics in NYC to offer AviClear to help our patients dealing with acne,” says Dr. Morgan Rabach.

NEW YORK (PRWEB)
November 07, 2022

For patients seeking non-surgical medical treatment for dermatological needs or wanting to explore cosmetic surgery, LM Medical NYC offers the best of both worlds at one state-of-the-art facility. As sisters and founders of the practice, Dr. Lesley Rabach, a board-certified facial plastic surgeon, and Dr. Morgan Rabach, a board-certified dermatologist, come together to provide the highest-quality medical, surgical and cosmetic care for patients. For those suffering from moderate to severe acne, AviClear is a new laser acne treatment that offers a safe, prescription-free solution. This revolutionary treatment offered at LM Medical NYC resolves acne at the source by selectively targeting the sebocytes and suppressing sebum production. Existing device treatments for acne are neither long-lasting nor particularly effective, and topical therapies yield temporary results and oral medications present several challenges. AviClear offers patients a safe, well-tolerated, drug-free approach with durable results, which significantly shifts the treatment paradigm for acne. Treatment is given in three sessions, one month apart, and has a similar clearance rate to Accutane (oral medication) with no creams or pills needed. In addition to reducing existing acne, future breakout episodes are shown to be shorter, less intense and more infrequent following the AviClear procedure. Acne clearance results continue to improve over time, demonstrating the long-term efficacy of this novel treatment.

“Physicians and patients have long sought a modern alternative to acne pills, peels and topicals, we are excited to be one of the few clinics in NYC to offer AviClear to help our patients dealing with acne,” says Dr. Morgan Rabach.

More about LM Medical NYC:

LM Medical NYC’s clinic is located at 33 Fifth Avenue #1B in New York, NY, and provides cutting-edge cosmetic surgery and skin care treatments The practice offers expertise in two fields of medicine to help patients achieve the appearance they desire. Dr. Lesley Rabach is double board certified in two facial plastic surgery fields, with a stellar reputation for creating natural, exquisite results for patients. Her extensive education, training and experience have earned accolades in her field, and she has been published in various medical journals. Dr. Morgan Rabach is a board-certified dermatologist who also has been recognized for her many accomplishments in dermatology and aesthetics. She has received many top rankings in her field and has a substantial media presence in well-known beauty publications around the world. For more information or to schedule a consultation or appointment, please call (212) 777-2272, or visit http://www.lmmedicalnyc.com.

Share article on social media or email:

Jim McGrann, CEO of Professional Eyecare Associates of America (PECAA), named Chair of the Prevent Blindness Board of Directors.

“I’m looking forward to working closely with Jim McGrann in his new leadership role at Prevent Blindness,” said Jeff Todd, president and CEO.

CHICAGO (PRWEB)
November 07, 2022

Prevent Blindness, the nation’s leading volunteer eye health and safety nonprofit organization, has announced that Jim McGrann, CEO of Professional Eyecare Associates of America (PECAA), has been appointed Chair of the Prevent Blindness Board of Directors. PECAA was recently acquired by VSP Vision. Susan A. Primo, OD, MPH, FAAO, Director, Optometry and Vision Rehabilitation Services, Emory Eye Center, and Professor of Ophthalmology, Emory University School of Medicine, and Susan L. Stone, Founder of SLStone Consulting, LLC, have been elected as members of Prevent Blindness Board of Directors. The vote was held on Nov. 4, at the 2022 Prevent Blindness Annual Board Meeting in Chicago.

Stephanie Marioneaux, MD, cornea and external disease specialist, was elected as Board Secretary, and Cadmus Rich, MD, MBA, Chief Medical Officer and Head of Research and Development at Aura Biosciences, was re-elected as Board Treasurer. Marcus Molea, long-time Prevent Blindness, Ohio Affiliate volunteer, retired from the Ohio Department of Aging, was named the Chief Volunteer Officer liaison to the Board.

Jim McGrann was named the Prevent Blindness Board of Directors Chair-elect in 2021 and takes over duties from Board of Directors Chair, Dr. M. Kathleen Murphy, Associate Dean, Inclusivity, Global Health & Community Engagement, University of Texas Medical Branch School of Nursing, at the completion of her term.

Mr. McGrann has decades of executive experience in the vision and optical industry. At PECAA, McGrann manages business strategy development, customer experience management, and information technology strategy development. He was previously the President & CEO of VSP Global, the former President of VSP Vision, and CIO of Marchon Eyewear. He has a Bachelor of Science in industrial engineering from Columbia University.

McGrann has served on various Prevent Blindness event committees over the years, including co-chairing the 2021 Person of Vision Award committee, honoring Marc Ferrara of Jobson Medical Information.

In addition to her public health work, Dr. Susan Primo specializes in vision rehabilitation to assist patients who become visually impaired through the evaluation and prescription of low vision devices. Her research interests are in strategic public health approaches to address visual impairment and loss (especially due to glaucoma) and to reduce racial disparities in vision healthcare. She is a known expert in low vision/vision rehabilitation research as well as visual health disparities.

Dr. Primo is involved in multiple global ophthalmology projects including Georgia Vision 2020 and Standing Voice service visits to Tanzania. Additionally, she is a member of National Eye Health and Education Planning Group from the National Eye Institute, and she is the Co-chair of the Center for Vision and Population Health at Prevent Blindness Advisory Committee. She also serves on the Prevent Blindness Vision Health Equity Committee, and on the Advisory Council to the Living Well with Low Vision Resource. She has also served on the Prevent Blindness Scientific Committee and as a volunteer for Prevent Blindness Georgia.

At SLStone Consulting, Susan Stone creates connections between for-profit clients and patient, provider and policymaker coalitions and nonprofit organizations, that amplify all stakeholder voices to ensure patient access to appropriate healthcare treatments and services. She develops communications strategies and campaigns that influence activations across a diversity of willing and able advocates. Prior to her consulting work, Ms. Stone has decades of experience in the vision health and biopharmaceutical industries, including Associate Vice President, Global Alliance Advocacy & Patient Affairs at Allergan, plc, (now AbbVie), and as a Board Member for The Allergan Foundation, and Trustee for the Allergan International Foundation. Prior to Allergan, she held numerous leadership roles at Johnson & Johnson across their Medical Device, Biopharma, and Consumer sectors. Ms. Stone has a Bachelor of Science in Marketing from San Jose State University, and Master of Business Administration in Management from Golden Gate University.    

In addition to joining the Board of Directors, Susan Stone, currently a member of the Prevent Blindness Development Committee, will now serve as the committee’s Chair. She is also a board member of the National Headache Foundation and a consulting advisor for the Aimed Alliance.

“I’m looking forward to working closely with Jim McGrann in his new leadership role at Prevent Blindness,” said Jeff Todd, president and CEO. “And I thank Dr. Susan Primo, Susan Stone, and Marc Molea for their years of dedicated commitment to Prevent Blindness, and enthusiastically welcome them to our Board.”

For a full listing of members of the Prevent Blindness Board of Directors, please visit https://www.preventblindness.org/prevent-blindness-board-directors. For more information about Prevent Blindness or general eye health information, visit preventblindness.org.

About Prevent Blindness

Founded in 1908, Prevent Blindness is the nation’s leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, visit us at preventblindness.org, and follow us on Facebook, Twitter, Instagram, LinkedIn and YouTube.

###

Share article on social media or email:

“EmeritusDX is dedicated to expanding our services to ensure patient care is served and clinical outcomes are improved.” Robert Embree, Chief Executive Officer of EmeritusDX.

IRVINE, Calif., and SAN JOSE, Calif. (PRWEB)
November 07, 2022

EmeritusDX and KDx Diagnostics announced today the partnership to provide the URO17 test for the detection of bladder cancer. URO17 is a non-invasive urine test with high sensitivity and negative predicted value (NPV) that can be used to determine the status of active bladder cancer and to improve patient diagnosis. This is also likely to improve the treatment path as URO17 is also now available as a Laboratory Developed Test (LDT) in the United States. EmeritusDX will offer URO17 testing to Urology practices across the country.

With over 85,000 new cases of bladder cancer in the United States every year the most common symptom of bladder cancer is hematuria, or blood in the urine, and patients with hematuria need to be subjected to invasive cystoscopic procedures even though a large majority of patients with micro-hematuria will not have bladder cancer. The URO17 test, and its high sensitivity and NPV for bladder cancer, will assist in ruling these patients out for unnecessary cystoscopy and its invasive procedure and in turn reduce the work-up.

“We are very excited to partner with EmeritusDX, a premier cancer diagnostics and information company in the US, to make our URO17 test and information available to their network of urologists. Through EmeritusDX, urologists will have direct access to ordering URO17 Laboratory Developed Test for patients at risk of bladder cancer,” says Sholeh Jahanfard, President of KDx Diagnostics Inc.

“EmeritusDX is thrilled to present this additional test offering to the clients we serve. The URO17 LDT test adds efficiency and precision to the care of patients with bladder cancer. EmeritusDX is dedicated to expanding our services to ensure patient care is served and clinical outcomes are improved,” says Robert Embree, Chief Executive Officer of EmeritusDX.

URO17 LDT is currently validated and available for ordering through EmeritusDX

About EmeritusDX

EmeritusDX is a cancer diagnostics and information company. Our expertise is in delivering actionable clinical information. Within our world-class laboratory, we perform testing that guides the diagnosis and treatment of cancer patients. Our partners include hospital and private pathology practices, biotechnology companies, academic institutions, contract research and pharmaceutical development organizations, and more. We understand the dependency on our accurate and timely results and our commitment to excellence in this regard is unwavering.

About KDx Diagnostics Inc.

Founded in 2017, KDx is focused on developing non-invasive cancer tests to improve early detection and therapy decisions in cancer. The URO17 bladder cancer test developed by KDx may prove to be the most sensitive and specific for bladder cancer developed to date. KDx plans to develop tests based on the same biomarker for other platforms and sample types and expand its product line into other cancer diagnostic tests. URO17 is available as LDT in the U.S.

If you would like more information about this topic, please call 800-959-2846 or email cs@emeritusdx.com

Share article on social media or email:

Clark County extends Fresh Start WASH & Wellness program through June 2023.

Clark County Government with continue operating their three mobile showers as part of their effort to support the unhoused community through Clean the World Foundation’s Fresh Start WASH & Wellness Program through June 2023.

LAS VEGAS (PRWEB)
November 07, 2022

Clean the World Foundation, a leader in global health dedicated to water, sanitation, and hygiene (WASH) and global sustainability, has extended their Fresh Start WASH & Wellness Program that provides mobile showers and other wrap-around services to the unsheltered community in Clark County, NV, with Clark County Government. Clark County Government with continue operating their three mobile showers as part of their effort to support the unhoused community of Clark County through Clean the World Foundation’s Fresh Start WASH & Wellness Program. Clean the World Foundation, the nonprofit entity for the Clean the World enterprise, is the organization that operates the three mobile showers.

Since the program’s inception in 2017, Clean the World Foundation has delivered close to 41,000 showers, distributed over 55,000 hygiene kits, and contributed towards a 15% decrease in the rate of homelessness within the first six months. Through this program, partner service providers have seen an increase of over 55% in referrals on the days that the mobile showers are scheduled.

The three Clark County mobile showers alone have provided over 35,000 warm showers, through twelve showers including four ADA compliant stalls. Clean the World Foundation has distributed close to 46,000 hygiene kits and connected countless individuals to wrap-around services at partner host sites including free mental health or substance abuse assessments, food assistance, help getting identification, clean clothes, healthcare, veterinary care for animals, job placement training, and housing assistance. In 2022, 41 special events were hosted, 173 covid test were distributed, and 344 haircuts were given. The continuation of the Fresh Start WASH & Wellness Program provides the opportunity to serve the unhoused with the services needed to ultimately accelerate the successful transition of members of this community to housing, treatment, job placement, and self-sufficiency.

Clark County Government fabricated the three Fresh Start Mobile Showers and has been a significant partner over the years in facilitating introductions and launching this program across southern Nevada. The operational costs of one of the three mobile showers is sponsored by Caesars Entertainment and Caesars Foundation.

“The extension of the Fresh Start WASH & Wellness Program in Clark County means we will be able to connect individuals experiencing homelessness and economic hardship to critical hygiene and wellness services,” says Manohar Shenoy, Executive Director, Clean the World Foundation. “Access to clean water, soap, and washing facilities reduce the risk of infection and illness from within the homeless population, as well as the spread of viruses like COVID-19 to the community at large and through this extension, our public-private partnership with Clark County Government, Caesars Entertainment, and Caesars Foundation will continue to positively impact the state of Nevada in a substantial way.”

You can make a difference in your local community. Clean the World is looking for additional sponsors to help cover the operational cost of the Fresh Start WASH and Wellness Program. Businesses that want to get involved, please contact freshstart@cleantheworld.org for more information or visit: https://cleantheworldfoundation.org/freshstart/.

About Clean the World Foundation

Clean the World Foundation is an international development and global health nonprofit operating hygiene-focused emergency relief initiatives, and WASH (water, sanitation, and hygiene) education programs, targeting vulnerable communities in the United States and around the world. Founded in 2009, Clean the World Foundation is the 501(c)(3) non-profit sector of Clean the World’s social enterprise responsible for all soap and hygiene kit distribution both domestically and globally as part of many of its comprehensive WASH programs. Clean the World Foundation engages volunteers, donors, and other outcome-focused organizations around the world to provide hygiene supplies and education curriculum to support its global health programs. A copy of the official registration and financial information for Clean the World Foundation may be obtained from the Division of Consumer Services by visiting https://www.fdacs.gov/ConsumerServices. For more information, visit us online: https://www.cleantheworldfoundation.org.

About Clark County Government

Clark County is a dynamic and innovative organization dedicated to providing top-quality service with integrity, respect, and accountability. With jurisdiction over the world-famous Las Vegas Strip and covering an area the size of New Jersey, Clark is the nation’s 11th-largest county and provides extensive regional services to 2.3 million citizens and 45.6 million visitors a year (2019). Included are the nation’s 9th-busiest airport, air quality compliance, social services, and the state’s largest public hospital, University Medical Center. The County also provides municipal services that are traditionally provided by cities to 1 million residents in the unincorporated area. Those include fire protection, roads and other public works, parks and recreation, and planning and development.

Share article on social media or email:

Low patient numbers, an incomplete understanding of the disease pathology, phenotypic heterogeneity and a lack of established endpoints are barriers to efficient and effective clinical trials.

TORONTO (PRWEB)
November 07, 2022

Co-creation with patients is vital for effective clinical trial design. A study by Skovlund, PC, Nielsen, BK, Thaysen, HV et al. shows that, in clinical trials, “patient involvement can lead to improvements in design, selection of relevant outcome measures and effective recruitment of trial participants.”

For a medicine to be authorised, clinical efficacy and safety need to be established, usually through robust and relevant clinical trial data. There are several unique challenges in the development of orphan disease treatments. Low patient numbers, an incomplete understanding of the disease pathology, phenotypic heterogeneity and a lack of established endpoints are barriers to efficient and effective clinical trials.

A key aspect is the choice and selection of the primary and key secondary efficacy endpoints: a reliable, valid, sensitive, interpretable and meaningful endpoint is vital to a well-designed study. This is necessary both as the basis to demonstrate the clinical impact of any therapeutic intervention and to stand up to regulatory scrutiny.

In this webinar, attendees will learn how Aparito’s Patient Group Accelerator Programme enables patients to co-create alongside sponsors & CROs. The Accelerator is designed to understand and fulfil patients’ needs by working closely with patient organisations and finding new endpoints that are relevant to their specific conditions.

The featured speakers speak to a young patient to gain their perspective on being involved with clinical trial design and they demonstrate how this feedback can be taken into study design as they close out the session with a real-life example from Aparito’s Accelerator programme.

Register to learn the value of patient co-creation in clinical trial design and how patient involvement can improve trial design and clinical outcome measures.

Join Begonya Nafría, Patients Engagement in Research Coordinator, Sant Joan de Déu Children’s Hospital Barcelona; Nora Navarro, Patient, Kids Barcelona; Lucy Dixon, Chair, PCD Support UK; and Elisa Ferrer Mallol, Patient Advocacy Manager, Aparito, for the live webinar on Wednesday, November 23, 2022, at 10am EST (4pm CET/EU-Central).

For more information, or to register for this event, visit The Value of Patient Co-Creation in Clinical Trial Design.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

We are dedicated to expanding our footprint in the area that is currently underserved while attracting talented teammates who are as committed to the community as we are.

FREDERICK, Md. (PRWEB)
November 07, 2022

Compassionate, state-of-the-art urgent, emergency, and specialty care for pet families is coming to Frederick, Maryland.

Helmed by a reputable team of female entrepreneurs, Partner Veterinary Emergency & Specialty Center (PVESC) is thrilled to announce plans for its newest location, opening at the Frederick Crossing shopping plaza. Located at 7330 Guilford Drive in the former A.C. Moore location, the 20,000-square-foot facility provides support to an economically growing market. PVESC anticipates hiring over 70 team members to help pets and their families receive 24-hour emergency services and related urgent and specialty care access.

With Frederick County experiencing years of rapid growth, PVESC President and Frederick local, Christine Stafford, recognized a need for a variety of enhanced pet care options when primary veterinary offices are closed or unavailable. “The new location is a great fit for us and the community. New businesses opening their doors is a positive sign of economic growth, and we are honored to be a part of the Frederick community in this capacity,” Stafford shared. The facility will create full- and part-time positions, including Veterinary Specialists, ER Doctors, Care Advocates, and Nursing Support. “We are dedicated to expanding our footprint in the area that is currently underserved while attracting talented teammates who are as committed to the community as we are,” she said.

With construction soon underway, the location is expected to be ready by spring 2023 and will offer three tiers of services under one roof. Urgent Care sees pets suffering from issues like allergic reactions, vomiting, or eye and skin irritation. Emergency Care will be offered for cases such as acute trauma, heatstroke, or weakness. The Specialty Care arm of the practice provides internal medicine, neurology, medical oncology, surgery, and in-house MRI and CT.

PVESC CEO Katie Brooks is dedicated to affecting positive changes in her profession and looks forward to Partner Veterinary immersing itself in the Frederick community. “I started in this industry to heal pets. I stay in it to support people and provide pet families with top-notch care, all while reimagining what a team-first approach and true life balance look like within my profession.” Brooks is looking forward to bringing this approach to Frederick as well as connecting with other local caregivers. “It’s important to us that we build strong partnerships with primary care veterinarians so they know they can trust us to provide continuity of care for Frederick-area pet families,” she added.

To submit your resume for a Frederick-based position at the new location, please visit https://partnervesc.com/careers.

Based in Frederick, Maryland, Partner Veterinary Emergency & Specialty Center (PVESC) is a women-helmed business whose mission is to transform the veterinary profession. They are healing a challenged industry from the inside out by taking a team-first approach to veterinary care. They have a reputation for building and retaining happy, healthy teams—and founded Partner Veterinary to give more professionals a supportive environment to do the job they love.

Share article on social media or email:

Remote cardiac monitoring systems with extensive data storage, round-the-clock patient monitoring, and real-time data deliver the information physicians need to provide the best available care

WALTHAM, Mass. (PRWEB)
November 07, 2022

When patients are critically ill, intrahospital transport (IHT), moving patients within the hospital, can cause significant complications.(1) Patients may be moved to other hospital areas for diagnostic testing or transferred to another unit. Regardless of the length of stay in the hospital, IHT statistically increases the risk of complications and death.(2) Nearly half of all patients transported within a hospital experience an adverse event.(3) To minimize the risk, IHT must be well-planned, executed efficiently, and include the proper monitoring equipment and staff. Equipment needs to be set up for transport without the risk of tangled cords or lost power. When an IHT is executed by trained personnel using remote telemetry, even critically ill patients can be safely transported.(4)

The most effective transport monitoring systems can eliminate dangerous data gaps during transportation. Cardiac monitors are a vital component of IHT for critically ill patients. They must seamlessly interface with a subset of mobile diagnostic devices, as well as hospital IT systems. Wireless systems like remote cardiac monitoring can improve care during IHT by ensuring that the patient’s vital signs and ECG are continuously tracked.

“Remote cardiac monitoring systems with extensive data storage, round-the-clock patient monitoring, and real-time data deliver the information physicians need to provide the best available care,” says Stuart Long, CEO of InfoBionic, a Massachusetts-based digital health company.

In addition to reducing the risks associated with IHT, advanced virtual telemetry can meet the needs of most patients, no matter where they are in the hospital. Some areas, like the ICU, have sophisticated stationary cardiac monitors that are mostly confined to one hospital area, leaving the potential for patients to go without adequate monitoring when transported to non-telemetry areas like radiology or cardiology.

Patients requiring a higher level of telemetry and complex medical equipment typically occupy hospital beds for a more extended period. Low-acuity patients can benefit from remote monitoring in less critical areas of the hospital or even in their own homes, liberating hospital beds for more acute patients.

InfoBionic is introducing the cloud-based MoMe™ ARC (Advanced Remote Cardiology) Platform that is intended to capture and deliver real-time cardiac data to near real-time cardiac monitoring data as patients shift from inpatient to outpatient. There are no limits to the level of medical complexity. The MoMe™ ARC Platform will allow for noninvasive and continuous cardiac monitoring for low-acuity to higher-acuity patients in both inpatient and outpatient settings. MoMe™ ARC technology is intended to support a range of compatible third-party RPM (remote patient monitoring) devices, such as blood pressure cuffs, oximeters, and scales.

Infobionic’s remote cardiac telemetry monitoring system has the potential to reduce IHT risks, allowing for consistent, round-the-clock monitoring while possibly freeing up valuable in-hospital beds for higher-acuity patients and simultaneously providing continuous cardiac monitoring from hospital to home.

About InfoBionic

InfoBionic’s digital technology has transformed the efficiency and economics of cardiac remote patient monitoring. The company’s MoMe ARC platform vision is to remove the roadblocks hindering remote diagnosis and decision-making. The Massachusetts-based team of seasoned entrepreneurs have had successful careers in healthcare, IT, medical devices, and mobile technology and bring specific expertise in remote monitoring and cardiology. Visit https://InfoBionic.com/

References: 

1) Knight, Patrick; Maheshwari, Neelabh; Hussain, Jafar; Scholl, Michael; Hughes, Michael; Papadimos, Thomas; Alan Guo, Weidun; Cipolla, James; Stawicki, Stanislaw; Latchana, Nicholas. “Complications during intrahospital transport of critically ill patients: Focus on risk identification and prevention.” 2015, PubMed Central, ncbi.nlm.nih.gov/pmc/articles/PMC4705572/.

2) Sokol-Hessner, Lauge; White, Andrew; Davis, Katherine; Herzig, Shoshana; Hohmann, Samuel. “Interhospital transfer patients discharged by academic hospitalists and general internists: Characteristics and outcomes.” November 14, 2015, National Library of Medicine, pubmed.ncbi.nlm.nih.gov/26588825/

3) Hajjej Z, Gharsallah H, Boussaidi I, Daiki M, Labbene I, Ferjani M. Risk of mishaps during intrahospital transport of critically ill patients[abstract]. Tunis Med. 2015 pubmed.ncbi.nlm.nih.gov/27126429/

4) Sethi, Divya; Subramanian, Shalini. “When place and time matter: How to conduct safe inter-hospital transfer of patients.” 2014, National Library of Medicine, ncbi.nlm.nih.gov/pmc/articles/PMC3950432/

Share article on social media or email: